Tag: Spinal muscular atrophy
PTC Therapeutics collaborates with Royalty Pharma in $1.5bn Evrysdi royalty agreement
PTC Therapeutics, Inc. (NASDAQ: PTCT) has forged an agreement with Royalty Pharma plc., monetizing up to a staggering $1.5 billion from the Evrysdi royalty stream. ... Read More
Novartis to buy US gene therapy company AveXis for $8.7bn
Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion deal to acquire US gene therapy company AveXis in a move ... Read More